HeartBeam, Inc. (Nasdaq: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, entered into an At-The-Market Offering Agreement providing for the sale of up to $25 million of shares of its common stock.
Pursuant to the agreement, the Company was permitted to offer and sell shares of its common stock from time to time through Titan Partners Securities LLC, which acted as sales agent. Sales were permitted to be made in transactions deemed to be “at-the-market offerings,” including sales made directly on or through the Nasdaq Capital Market at prevailing market prices.
The offering provided HeartBeam with additional flexibility to access the public capital markets and raise capital from time to time based on market conditions and the Company’s financing needs.
Titan Partners Securities LLC acted as sales agent for the offering. Lucosky Brookman LLP served as legal counsel to HeartBeam, Inc. in connection with the At-The-Market Offering.
